Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
FTAI Aviation buys 27 Boeing 737-700 jets from WestJet

FTAI Aviation buys 27 Boeing 737-700 jets from WestJet

BitgetBitget2026/09/28 10:01
  • FTAI Aviation acquired 27 Boeing 737-700 aircraft from WestJet in one of its largest aircraft transactions.
  • Its 2026 SPV bought 17 aircraft on lease to WestJet via a sale-leaseback.
  • FTAI also acquired 10 off-lease aircraft to feed its Aerospace Products business with CFM56-7B engines and modules.
  • The 2026 SPV targets mid-life 737NG and A320ceo aircraft.
  • The earlier 2025 SPV raised USD 2 billion in equity commitments, committing about USD 6 billion across more than 300 aircraft.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. FTAI Aviation Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609280600PRIMZONEFULLFEED9834641) on September 28, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Uncertainty clouds the US stock IPO market as smart ring manufacturer Oura (OURA.US) joins the ranks of delayed listings

Oura (OURA.US) has become the latest company to postpone its initial public offering (IPO) in the United States due to market uncertainty.

智通财经•2026/09/29 11:36

AstraZeneca (AZN.US) invests in Summit (SMMT.US), gaining positive outlooks from JPMorgan and Citi: Cancer drug strategy awaits validation

Analysts from JPMorgan and Citi have welcomed the deal between AstraZeneca and Summit Therapeutics, stating that it aligns with AstraZeneca's cancer strategy.

智通财经•2026/09/29 11:06